Novo Nordisk Rebrands as 'Novo' for Everyday Use, Launches New Cultural Framework
Pharmaceutical company Novo Nordisk (NYSE:NVO) has announced a rebranding initiative where it will use the name 'Novo' in its everyday operations while retaining 'Novo Nordisk A/S' as its legal global entity. The move is part of an effort to create a more consistent identity across medicines, partnerships, and stakeholder communications. Alongside the new operating name, Novo introduced a cultural framework called 'The Novo Way,' built on four principles: customer obsession, competitiveness, clarity, and care and integrity. CEO Mike Doustdar emphasized that these changes aim to make healthcare more responsive and relevant in everyday life while reinforcing strategic operations and competition. Novo Nordisk plans to present its updated corporate strategy at a Capital Markets Day event scheduled for September 21 in London.
Tickers: $NVO